Late dofetilide-associated life-threatening proarrhythmia

International Journal of Cardiology

Volumn 127, Issue 2, 2008, Pages

  Kolb, Christof ^a   Ndrepepa, Gjin ^a   Zrenner, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antiarrhythmics; Atrial fibrillation; Defibrillator; Dofetilide; Implantable cardioverter; Proarrhythmia

Indexed keywords

BISOPROLOL; DOFETILIDE;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; DEFIBRILLATION; DEFIBRILLATOR; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROGRAPHY; HEART ATRIUM FIBRILLATION; HEART PROARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MALE; PRIORITY JOURNAL; SINUS RHYTHM; SYNCOPE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; PHENETHYLAMINES; SULFONAMIDES; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 44649132480     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.014     Document Type: Article

References (7)

1. Torp-Pedersen C., Møller M., Bloch-Thomsen P.E., et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 341 (1999) 857-865
2. Singh S., Zoble R.G., Yellen L., et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102 (2000) 2385-2390
3. Prystowsky E.N., Freeland S., Branyas N.A., et al. Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. J Cardiovasc Electrophysiol 14 (2003) S287-S290
4. Nagra B.S., Ledley G.S., and Kanthara B.K. Marked prolongation and torsade de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale. J Cardiovasc Pharmacol Ther 10 (2005) 191-195
5. Reiffel J.A. Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes. Pacing Clin Electrophysiol 28 (2005) 877-879
6. Glikson M., Gurevitz O.T., Trusty J.M., et al. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions. Am J Cardiol 94 (2004) 1445-1449
7. Kirilmaz A., Dokumaci B., Uzun M., et al. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation. Pacing Clin Electrophysiol 28 (2005) 498-505